Family offices are no longer being viewed simply as another pool of capital for private markets. Across Asia, the more sophisticated families are acting as LPs, co-investors, direct investors, club-deal participants and, in some cases, strategic partners with operating networks, sector knowledge and patient capital that traditional institutions may not always bring. But that shift also raises harder questions. When should a family office back a GP, co-invest alongside one, buy into a secondary opportunity or pursue a direct deal on its own? What do families expect in terms of access, governance, transparency, fees, liquidity and alignment? And how should GPs engage family offices without treating them as just a fundraising shortcut? This panel will examine how Asia’s family offices are reshaping private markets, where their capital is most useful, and what both sides need to get right for these relationships to become durable.
